Dr. Giantonio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
15 Penn Tower
Philadelphia, PA 19104Phone+1 215-662-3914
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
- University of Vermont Medical CenterResidency, Internal Medicine, 1987 - 1990
- Georgetown University School of MedicineClass of 1987
Certifications & Licensure
- MA State Medical License 2017 - 2026
- NH State Medical License 2024 - 2024
- ME State Medical License 2020 - 2021
- PA State Medical License 1990 - 2021
- VT State Medical License 1987 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 2000 Nov 01
- Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated Start of enrollment: 2001 Sep 01
- Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer Start of enrollment: 2003 Oct 15
- Join now to see all
Publications & Presentations
PubMed
- Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.Romain Cohen, Morteza Raeisi, Benoist Chibaudel, Qian Shi, Takayuki Yoshino
European Journal of Cancer. 2024-08-01 - 3 citationsPatient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.Joy X Jarnagin, Anurag Saraf, Islam Baiev, Gary Chi, Emily E van Seventer
JAMA Network Open. 2023-11-01 - Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma.Ofer Margalit, Einat Shacham-Shmueli, Gal Strauss, Yu-Xiao Yang, Yaacov R Lawrence
Cancer Investigation. 2023-09-01
Authored Content
- A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
- A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
- A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
Press Mentions
- Donegal Woman Finally Starts Lifesaving Cancer Treatment in USAugust 18th, 2021
- Racial Disparities in Colon Cancer Survival PersistDecember 30th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: